These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21453380)

  • 41. Canonical Chinese medicine formula Danzhi-Xiaoyao-San for treating depression: A systematic review and meta-analysis.
    Wang XL; Feng ST; Wang YT; Zhang NN; Wang ZZ; Zhang Y
    J Ethnopharmacol; 2022 Apr; 287():114960. PubMed ID: 34968660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis.
    Javelle F; Lampit A; Bloch W; Häussermann P; Johnson SL; Zimmer P
    Nutr Rev; 2020 Jan; 78(1):77-88. PubMed ID: 31504850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lessons learned from placebo groups in antidepressant trials.
    Mora MS; Nestoriuc Y; Rief W
    Philos Trans R Soc Lond B Biol Sci; 2011 Jun; 366(1572):1879-88. PubMed ID: 21576145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic review and meta-analysis to estimate potential recruitment to dementia intervention studies.
    Cooper C; Ketley D; Livingston G
    Int J Geriatr Psychiatry; 2014 May; 29(5):515-25. PubMed ID: 24706605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses.
    Sarris J; Murphy J; Mischoulon D; Papakostas GI; Fava M; Berk M; Ng CH
    Am J Psychiatry; 2016 Jun; 173(6):575-87. PubMed ID: 27113121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings.
    Fountoulakis KN; McIntyre RS; Carvalho AF
    Curr Neuropharmacol; 2015; 13(5):605-15. PubMed ID: 26467410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting antidepressant response through early improvement of individual symptoms of depression incorporating baseline characteristics of patients: An individual patient data meta-analysis.
    Watanabe N; Maruo K; Imai H; Ikeda K; Yamawaki S; Furukawa TA
    J Psychiatr Res; 2020 Jun; 125():85-90. PubMed ID: 32247194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Believe in what you practice].
    Sommer IE; Evers AWM
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methodology of measuring the efficacy of antidepressants.
    Quitkin FM
    Psychopharmacology (Berl); 1992; 106 Suppl():S87-9. PubMed ID: 1546150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there a genuine placebo effect in acute depression treatments? A reassessment of regression to the mean and spontaneous remission.
    Hengartner MP
    BMJ Evid Based Med; 2020 Apr; 25(2):46-48. PubMed ID: 30975717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of Response and Remission to Antidepressants in Geriatric Depression: A Systematic Review.
    Masse-Sibille C; Djamila B; Julie G; Emmanuel H; Pierre V; Gilles C
    J Geriatr Psychiatry Neurol; 2018 Nov; 31(6):283-302. PubMed ID: 30477416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance.
    Costello H; Roiser JP; Howard R
    Psychol Med; 2023 Feb; 53(3):654-667. PubMed ID: 36621964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What have antidepressants been tested for? A systematic review.
    Gøtzsche PC; Dinnage O
    Int J Risk Saf Med; 2020; 31(3):157-163. PubMed ID: 32444565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient reported outcome measures in clinical trials should be initially analyzed as continuous outcomes for statistical significance and responder analyses should be reserved as secondary analyses.
    Collister D; Bangdiwala S; Walsh M; Mian R; Lee SF; Furukawa TA; Guyatt G
    J Clin Epidemiol; 2021 Jun; 134():95-102. PubMed ID: 33561528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Examining antidepressant drug response by smoking status: why is it important and how often is it done?
    Weinberger AH; McKee SA; Picciotto MR; Mazure CM
    J Psychopharmacol; 2011 Oct; 25(10):1269-76. PubMed ID: 21169392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An old but still burning problem: Inter-rater reliability in clinical trials with antidepressant medication.
    Berendsen S; Verdegaal LMA; van Tricht MJ; Blankers M; Van HL; de Haan L
    J Affect Disord; 2020 Nov; 276():748-751. PubMed ID: 32736184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic review and meta-analysis of the effects of group painting therapy on the negative emotions of depressed adolescent patients.
    Yuan Z; Li B; Ye X; Zhu X
    Ann Palliat Med; 2021 Oct; 10(10):10744-10755. PubMed ID: 34763436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of restrictive entry criterion during the placebo lead-in period.
    Landin R; DeBrota DJ; DeVries TA; Potter WZ; Demitrack MA
    Biometrics; 2000 Mar; 56(1):271-8. PubMed ID: 10783806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy.
    Furukawa TA; Cipriani A; Leucht S; Atkinson LZ; Ogawa Y; Takeshima N; Hayasaka Y; Chaimani A; Salanti G
    Evid Based Ment Health; 2018 Feb; 21(1):1-3. PubMed ID: 29330216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circadian markers as a predictor of response in the treatment of depression-A systematic review.
    Druiven SJM; Hovenkamp-Hermelink JHM; Kamphuis J; Haarman BCM; Meesters Y; Riese H; Schoevers RA
    Psychiatry Res; 2024 Aug; 338():115976. PubMed ID: 38830322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.